EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation. (Q35472026)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation. |
scientific article |
Statements
EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation (English)
Patrick Trojer
William D Bradley
Shilpi Arora
Jennifer Busby
Srividya Balasubramanian
Victor S Gehling
Christopher G Nasveschuk
Rishi G Vaswani
Chih-Chi Yuan
Charlie Hatton
Feng Zhao
Kaylyn E Williamson
Priyadarshini Iyer
Jacqui Méndez
Robert Campbell
Nico Cantone
Shivani Garapaty-Rao
James E Audia
Andrew S Cook
Les A Dakin
Brian K Albrecht
Jean-Christophe Harmange
Danette L Daniels
Richard T Cummings
Emmanuel Normant
1 November 2014